NCT03504189View on ClinicalTrials.gov

Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

June 27, 2018

Study Completion Date

November 8, 2018

Conditions
Pregnancy
Interventions
DEVICE

PregSense™

PregSense™ wearable device will be applied for maternal-fetal monitoring

DEVICE

Cardiotocopraphy (CTG)

Cardiotocopraphy (CTG) will be applied for maternal-fetal monitoring

Trial Locations (4)

19104

Hospital of the University of Pennsylvania, Philadelphia

23507

Eastern Virginia Medical School, Norfolk

Unknown

Heidelberg University Womens Hospital, Heidelberg

Hadassah-Hebrew University Medical Center, Jerusalem

All Listed Sponsors
lead

Nuvo-Group, Ltd.

INDUSTRY

NCT03504189 - Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects | Biotech Hunter | Biotech Hunter